Breaking News Instant updates and real-time market news.

CASY

Casey's General Stores

$169.96 /

+5.12 (+3.11%)

08:37
09/11/19
09/11
08:37
09/11/19
08:37

Casey's General Stores price target raised to $170 from $140 at BMO Capital

BMO Capital analyst Kelly Bania raised her price target on Casey's General Stores to $170 after its Q1 results, saying the company's fuel price optimization has been driving its earnings since the beginning of its "value creation plan". The analyst notes that she sees continued runway in that trend, even though she warns that an acceleration in the in-store trends may be "difficult" to achieve, keeping her Market Perform rating on the stock. Bania still raises her FY20 and FY21 EPS views on Casey's General Stores by 77c and $1.15 to $6.41 and $6.80 respectively to reflect its higher fuel margins.

  • 13

    Nov

CASY Casey's General Stores
$169.96 /

+5.12 (+3.11%)

09/11/19 Wells Fargo
Casey's General Stores price target raised to $165 form $145 at Wells Fargo
09/10/19 Jefferies
Jefferies a buyer of Casey's ahead of this morning's earnings call
09/04/19 Jefferies
Casey's General Stores price target raised to $192 from $183 at Jefferies
09/03/19 Deutsche Bank
Casey's General Stores price target raised to $185 from $166 at Deutsche Bank

TODAY'S FREE FLY STORIES

Technical Analysis
Invesco QQQ Trust: Pivot points » 08:20
08/10/20
08/10
08:20
08/10/20
08:20
QQQ

Invesco QQQ Trust

$271.53 /

-3.04 (-1.11%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QQQ Invesco QQQ Trust
$271.53 /

-3.04 (-1.11%)

QQQ Invesco QQQ Trust
$271.53 /

-3.04 (-1.11%)

QQQ Invesco QQQ Trust
$271.53 /

-3.04 (-1.11%)

Technical Analysis
Nasdaq Composite: Pivot points » 08:20
08/10/20
08/10
08:20
08/10/20
08:20
$COMP

Nasdaq Composite

$0.00 /

+ (+0.00%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$COMP Nasdaq Composite
$0.00 /

+ (+0.00%)

Technical Analysis
Nasdaq 100 Index: Pivot points » 08:20
08/10/20
08/10
08:20
08/10/20
08:20
NDX

Nasdaq 100 Index

$0.00 /

+ (+0.00%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NDX Nasdaq 100 Index
$0.00 /

+ (+0.00%)

NDX Nasdaq 100 Index
$0.00 /

+ (+0.00%)

Recommendations
Guardion Health Sciences FDA approval landmark event, says Canaccord » 08:19
08/10/20
08/10
08:19
08/10/20
08:19
GH

Guardant Health

$85.79 /

+2.99 (+3.61%)

Canaccord analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GH Guardant Health
$85.79 /

+2.99 (+3.61%)

GH Guardant Health
$85.79 /

+2.99 (+3.61%)

06/12/20
Fly Intel: Top five analyst initiations
06/12/20 BTIG
BTIG starts genomic profiling test 'pioneer' Guardant Health at Buy
06/11/20 BTIG
Guardant Health initiated with a Buy at BTIG
05/08/20 Citi
Guardant Health price target raised to $110 from $100 at Citi
GH Guardant Health
$85.79 /

+2.99 (+3.61%)

  • 02
    Jun
GH Guardant Health
$85.79 /

+2.99 (+3.61%)

Hot Stocks
Radius Health expects cash to fund operations for at least 12 months » 08:19
08/10/20
08/10
08:19
08/10/20
08:19
RDUS

Radius Health

$11.98 /

+0.35 (+3.01%)

As of June 30, 2020,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDUS Radius Health
$11.98 /

+0.35 (+3.01%)

RDUS Radius Health
$11.98 /

+0.35 (+3.01%)

07/08/20 SVB Leerink
Radius Health downgraded to Market Perform from Outperform at SVB Leerink
05/13/20 Morgan Stanley
Radius Health downgraded to Equal Weight following Q1 report at Morgan Stanley
05/13/20 Morgan Stanley
Radius Health downgraded to Equal Weight from Overweight at Morgan Stanley
04/24/20
Fly Intel: Top five analyst initiations
RDUS Radius Health
$11.98 /

+0.35 (+3.01%)

Conference/Events
Trevena to host conference call » 08:19
08/10/20
08/10
08:19
08/10/20
08:19
TRVN

Trevena

$2.36 /

-0.06 (-2.48%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRVN Trevena
$2.36 /

-0.06 (-2.48%)

TRVN Trevena
$2.36 /

-0.06 (-2.48%)

09/03/19 H.C. Wainwright
Trevena's oliceridine 'close to the finish line,' says H.C. Wainwright
TRVN Trevena
$2.36 /

-0.06 (-2.48%)

TRVN Trevena
$2.36 /

-0.06 (-2.48%)

Earnings
Radius Health reports Q2 adj. EPS (67c), consensus (74c) » 08:18
08/10/20
08/10
08:18
08/10/20
08:18
RDUS

Radius Health

$11.98 /

+0.35 (+3.01%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDUS Radius Health
$11.98 /

+0.35 (+3.01%)

RDUS Radius Health
$11.98 /

+0.35 (+3.01%)

07/08/20 SVB Leerink
Radius Health downgraded to Market Perform from Outperform at SVB Leerink
05/13/20 Morgan Stanley
Radius Health downgraded to Equal Weight following Q1 report at Morgan Stanley
05/13/20 Morgan Stanley
Radius Health downgraded to Equal Weight from Overweight at Morgan Stanley
04/24/20
Fly Intel: Top five analyst initiations
RDUS Radius Health
$11.98 /

+0.35 (+3.01%)

Hot Stocks
AnaptysBio says etokimab did not demonstrate significance over placebo in study » 08:17
08/10/20
08/10
08:17
08/10/20
08:17
ANAB

AnaptysBio

$18.51 /

+0.7 (+3.93%)

AnaptysBio reported…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANAB AnaptysBio
$18.51 /

+0.7 (+3.93%)

ANAB AnaptysBio
$18.51 /

+0.7 (+3.93%)

01/16/20 Cantor Fitzgerald
AnaptysBio risk/reward favorable into second half data, says Cantor Fitzgerald
11/11/19 SunTrust
AnaptysBio downgraded to Hold from Buy at SunTrust
11/08/19 Cantor Fitzgerald
Cantor cuts AnaptysBio target to $28 from $140, sees value in shares
11/08/19 Jefferies
AnaptysBio downgraded to Hold from Buy at Jefferies
ANAB AnaptysBio
$18.51 /

+0.7 (+3.93%)

ANAB AnaptysBio
$18.51 /

+0.7 (+3.93%)

Recommendations
Installed Building Products price target raised to $105 from $87 at BTIG » 08:17
08/10/20
08/10
08:17
08/10/20
08:17
IBP

Installed Building Products

$85.92 /

+0.82 (+0.96%)

BTIG analyst Ryan Gilbert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IBP Installed Building Products
$85.92 /

+0.82 (+0.96%)

IBP Installed Building Products
$85.92 /

+0.82 (+0.96%)

06:50 Today Benchmark
Installed Building Products price target raised to $104 from $87 at Benchmark
08/07/20 Zelman
Installed Building Products upgraded to Buy from Hold at Zelman
07/16/20 BTIG
Installed Building Products, Builders FirstSource price targets raised at BTIG
07/08/20 SunTrust
SunTrust ups Installed Building Products, TopBuild, Builders FirstSource targets
IBP Installed Building Products
$85.92 /

+0.82 (+0.96%)

Hot Stocks
Arcadia Biosciences announces partnership with Three Farm Daughters » 08:15
08/10/20
08/10
08:15
08/10/20
08:15
RKDA

Arcadia Biosciences

$3.75 /

+0.01 (+0.27%)

Arcadia Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RKDA Arcadia Biosciences
$3.75 /

+0.01 (+0.27%)

RKDA Arcadia Biosciences
$3.75 /

+0.01 (+0.27%)

RKDA Arcadia Biosciences
$3.75 /

+0.01 (+0.27%)

Recommendations
Regeneron antibody cocktail important in beating COVID, says Canaccord » 08:15
08/10/20
08/10
08:15
08/10/20
08:15
REGN

Regeneron

$620.43 /

-0.7 (-0.11%)

Canaccord analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REGN Regeneron
$620.43 /

-0.7 (-0.11%)

REGN Regeneron
$620.43 /

-0.7 (-0.11%)

08/06/20 Oppenheimer
Regeneron price target raised to $725 from $675 at Oppenheimer
08/06/20 BMO Capital
Regeneron price target raised to $626 from $525 at BMO Capital
08/06/20 Barclays
Regeneron price target raised to $675 from $615 at Barclays
08/05/20 Piper Sandler
Regeneron price target raised to $675 from $630 at Piper Sandler
REGN Regeneron
$620.43 /

-0.7 (-0.11%)

  • 27
    May
REGN Regeneron
$620.43 /

-0.7 (-0.11%)

REGN Regeneron
$620.43 /

-0.7 (-0.11%)

REGN Regeneron
$620.43 /

-0.7 (-0.11%)

Hot Stocks
AnaptysBio expects cash, cash quivalents to fund plan at least into 2023 » 08:14
08/10/20
08/10
08:14
08/10/20
08:14
ANAB

AnaptysBio

$18.51 /

+0.7 (+3.93%)

AnaptysBio expects its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANAB AnaptysBio
$18.51 /

+0.7 (+3.93%)

ANAB AnaptysBio
$18.51 /

+0.7 (+3.93%)

01/16/20 Cantor Fitzgerald
AnaptysBio risk/reward favorable into second half data, says Cantor Fitzgerald
11/11/19 SunTrust
AnaptysBio downgraded to Hold from Buy at SunTrust
11/08/19 Cantor Fitzgerald
Cantor cuts AnaptysBio target to $28 from $140, sees value in shares
11/08/19 Jefferies
AnaptysBio downgraded to Hold from Buy at Jefferies
ANAB AnaptysBio
$18.51 /

+0.7 (+3.93%)

ANAB AnaptysBio
$18.51 /

+0.7 (+3.93%)

Earnings
AnaptysBio reports Q2 EPS (79c), consensus (75c) » 08:14
08/10/20
08/10
08:14
08/10/20
08:14
ANAB

AnaptysBio

$18.51 /

+0.7 (+3.93%)

Reports Q revenue $15M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ANAB AnaptysBio
$18.51 /

+0.7 (+3.93%)

ANAB AnaptysBio
$18.51 /

+0.7 (+3.93%)

01/16/20 Cantor Fitzgerald
AnaptysBio risk/reward favorable into second half data, says Cantor Fitzgerald
11/11/19 SunTrust
AnaptysBio downgraded to Hold from Buy at SunTrust
11/08/19 Cantor Fitzgerald
Cantor cuts AnaptysBio target to $28 from $140, sees value in shares
11/08/19 Jefferies
AnaptysBio downgraded to Hold from Buy at Jefferies
ANAB AnaptysBio
$18.51 /

+0.7 (+3.93%)

ANAB AnaptysBio
$18.51 /

+0.7 (+3.93%)

Initiation
Swiss Re resumed with an Equal Weight at Morgan Stanley » 08:14
08/10/20
08/10
08:14
08/10/20
08:14
SSREY

Swiss Re

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SSREY Swiss Re
$0.00 /

+ (+0.00%)

08/04/20 JPMorgan
Swiss Re price target lowered to CHF 93 from CHF 94 at JPMorgan
08/03/20 Deutsche Bank
Swiss Re Hold rating reaffirmed at Deutsche Bank after H1 results
07/23/20 JPMorgan
Swiss Re price target lowered to CHF 94 from CHF 96 at JPMorgan
07/07/20 JPMorgan
Swiss Re price target lowered to CHF 96 from CHF 98 at JPMorgan
SSREY Swiss Re
$0.00 /

+ (+0.00%)

SSREY Swiss Re
$0.00 /

+ (+0.00%)

Recommendations
Domtar price target raised to $26 from $21 at RBC Capital » 08:14
08/10/20
08/10
08:14
08/10/20
08:14
UFS

Domtar

$28.49 /

+6.02 (+26.79%)

RBC Capital analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UFS Domtar
$28.49 /

+6.02 (+26.79%)

UFS Domtar
$28.49 /

+6.02 (+26.79%)

06:36 Today Stephens
Domtar price target raised to $42 from $34 at Stephens
05:58 Today CIBC
Domtar downgraded to Underperformer from Neutral at CIBC
06/05/20 RBC Capital
Domtar downgraded to Sector Perform from Outperform at RBC Capital
06/05/20 RBC Capital
Domtar downgraded to Sector Perform from Outperform at RBC Capital
UFS Domtar
$28.49 /

+6.02 (+26.79%)

Hot Stocks
Leidos awarded $649M contract by ACC-APG » 08:13
08/10/20
08/10
08:13
08/10/20
08:13
LDOS

Leidos

$93.24 /

+2.23 (+2.45%)

Leidos has been awarded a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LDOS Leidos
$93.24 /

+2.23 (+2.45%)

LDOS Leidos
$93.24 /

+2.23 (+2.45%)

08/06/20 Stifel
Leidos share price reaction to earnings report 'puzzling,' says Stifel
06/11/20
Fly Intel: Top five analyst initiations
06/11/20 Baird
Baird starts Leidos at Outperform, sees growth poised to ramp next year
06/10/20 Baird
Leidos initiated with an Outperform at Baird
LDOS Leidos
$93.24 /

+2.23 (+2.45%)

LDOS Leidos
$93.24 /

+2.23 (+2.45%)

LDOS Leidos
$93.24 /

+2.23 (+2.45%)

Hot Stocks
Salesforce, CVS Health announce strategic relationship » 08:13
08/10/20
08/10
08:13
08/10/20
08:13
CRM

Salesforce

$200.83 /

-6.95 (-3.34%)

, CVS

CVS Health

$64.96 /

+0.87 (+1.36%)

Salesforce (CRM)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRM Salesforce
$200.83 /

-6.95 (-3.34%)

CVS CVS Health
$64.96 /

+0.87 (+1.36%)

CRM Salesforce
$200.83 /

-6.95 (-3.34%)

07/27/20 Morgan Stanley
Morgan Stanley downgrades Software industry view to In-Line from Attractive
07/14/20 Piper Sandler
Salesforce price target raised to $210 from $193 at Piper Sandler
06/24/20 Goldman Sachs
Salesforce price target raised to $220 from $204 at Goldman Sachs
06/22/20 Jefferies
Salesforce price target raised to $220 from $205 at Jefferies
CVS CVS Health
$64.96 /

+0.87 (+1.36%)

08/06/20 Deutsche Bank
CVS Health price target lowered to $104 from $109 at Deutsche Bank
07/29/20 RBC Capital
Livongo Health ending re-seller relationship with CVS Health, says RBC Capital
07/01/20 SVB Leerink
CVS Health reinstated with a Market Perform at SVB Leerink
06/01/20 Stephens
Molina Healthcare price target raised to $215 from $202 at Stephens
CRM Salesforce
$200.83 /

-6.95 (-3.34%)

CVS CVS Health
$64.96 /

+0.87 (+1.36%)

CRM Salesforce
$200.83 /

-6.95 (-3.34%)

CVS CVS Health
$64.96 /

+0.87 (+1.36%)

CRM Salesforce
$200.83 /

-6.95 (-3.34%)

CVS CVS Health
$64.96 /

+0.87 (+1.36%)

CRM Salesforce
$200.83 /

-6.95 (-3.34%)

CVS CVS Health
$64.96 /

+0.87 (+1.36%)

Earnings
Krystal Biotech reports Q2 EPS (37c), consensus (47c) » 08:13
08/10/20
08/10
08:13
08/10/20
08:13
KRYS

Krystal Biotech

$39.71 /

-0.29 (-0.73%)

"The future of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KRYS Krystal Biotech
$39.71 /

-0.29 (-0.73%)

KRYS Krystal Biotech
$39.71 /

-0.29 (-0.73%)

03/12/20 SMBC Nikko
Krystal Biotech initiated with an Outperform at SMBC Nikko
03/10/20 H.C. Wainwright
Krystal Biotech price target raised to $68 from $59 at H.C. Wainwright
09/26/19 Guggenheim
Krystal Biotech has 'room to run' despite doubling year-to-date, says Guggenheim
09/24/19 Goldman Sachs
Krystal Biotech initiated with a Neutral at Goldman Sachs
KRYS Krystal Biotech
$39.71 /

-0.29 (-0.73%)

  • 19
    May
Hot Stocks
Vitamin Shoppe names Muriel Gonzalez Chief Merchandising and Marketing Officer » 08:12
08/10/20
08/10
08:12
08/10/20
08:12
VSI

Vitamin Shoppe

$6.50 /

+ (+0.00%)

The Vitamin Shoppe…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Earnings
Ovid Therapeutics reports Q2 EPS (41c), consensus (36c) » 08:12
08/10/20
08/10
08:12
08/10/20
08:12
OVID

Ovid Therapeutics

$7.19 /

+0.28 (+4.05%)

"Ovid is in an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OVID Ovid Therapeutics
$7.19 /

+0.28 (+4.05%)

OVID Ovid Therapeutics
$7.19 /

+0.28 (+4.05%)

07/14/20 Citi
Ovid Therapeutics price target raised to $9 from $8 at Citi
06/18/20 Cantor Fitzgerald
Ovid Therapeutics price target raised to $13 from $7 at Cantor Fitzgerald
05/22/20 Cantor Fitzgerald
Zynerba price target raised to $21 from $12 at Cantor Fitzgerald
05/07/20 Piper Sandler
Ovid's gaboxadol data in Fragile X 'promising,' says Piper Sandler
OVID Ovid Therapeutics
$7.19 /

+0.28 (+4.05%)

  • 04
    Oct
OVID Ovid Therapeutics
$7.19 /

+0.28 (+4.05%)

OVID Ovid Therapeutics
$7.19 /

+0.28 (+4.05%)

Earnings
Motorcar Parts not providing FY21 guidance » 08:11
08/10/20
08/10
08:11
08/10/20
08:11
MPAA

Motorcar Parts

$19.01 /

+0.74 (+4.05%)

Motorcar Parts said in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MPAA Motorcar Parts
$19.01 /

+0.74 (+4.05%)

07/01/20 B. Riley FBR
Motorcar Parts transferred with Buy rating at B. Riley FBR
06/19/20 Roth Capital
Motorcar Parts assumed with a Buy at Roth Capital
11/13/19 Roth Capital
Motorcar Parts price target raised to $25 from $17 at Roth Capital
09/04/19 Roth Capital
Motorcar Parts resumed with a Buy at Roth Capital
MPAA Motorcar Parts
$19.01 /

+0.74 (+4.05%)

Hot Stocks
LiqTech reports Q2 EPS (12c), consensus (4c) » 08:11
08/10/20
08/10
08:11
08/10/20
08:11
LIQT

LiqTech

$6.70 /

-0.03 (-0.45%)

Reports Q2 revenue $4.6M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LIQT LiqTech
$6.70 /

-0.03 (-0.45%)

LIQT LiqTech
$6.70 /

-0.03 (-0.45%)

01/22/20 Lake Street
LiqTech analyst increases confidence in recovery, says Lake Street
12/17/19 Lake Street
LiqTech to recover from furnace throughput challenges, says Lake Street
11/14/19 Craig-Hallum
LiqTech post-earnings pullback a buying opportunity, says Craig-Hallum
09/06/19 Stephens
LiqTech can materially ramp revenue and profits in 2020, says Stephens
LIQT LiqTech
$6.70 /

-0.03 (-0.45%)

LIQT LiqTech
$6.70 /

-0.03 (-0.45%)

Hot Stocks
Rubius Therapeutics sees cash runway into 2022 » 08:11
08/10/20
08/10
08:11
08/10/20
08:11
RUBY

Rubius Therapeutics

$5.19 /

+0.04 (+0.78%)

As of June 30, 2020,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RUBY Rubius Therapeutics
$5.19 /

+0.04 (+0.78%)

RUBY Rubius Therapeutics
$5.19 /

+0.04 (+0.78%)

03/13/20 Morgan Stanley
Morgan Stanley cuts Rubius to Equal Weight after discontinuation of PKU program
03/13/20 Guggenheim
Rubius Therapeutics price target lowered to $11 from $23 at Guggenheim
03/13/20 SVB Leerink
Rubius Therapeutics downgraded at SVB Leerink after RTX-134 discontinuation
03/13/20 Morgan Stanley
Rubius Therapeutics downgraded to Equal Weight from Overweight at Morgan Stanley
RUBY Rubius Therapeutics
$5.19 /

+0.04 (+0.78%)

RUBY Rubius Therapeutics
$5.19 /

+0.04 (+0.78%)

Earnings
Rubius Therapeutics reports Q2 EPS (47c), consensus (50c) » 08:10
08/10/20
08/10
08:10
08/10/20
08:10
RUBY

Rubius Therapeutics

$5.19 /

+0.04 (+0.78%)

"Rubius Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RUBY Rubius Therapeutics
$5.19 /

+0.04 (+0.78%)

RUBY Rubius Therapeutics
$5.19 /

+0.04 (+0.78%)

03/13/20 Morgan Stanley
Morgan Stanley cuts Rubius to Equal Weight after discontinuation of PKU program
03/13/20 Guggenheim
Rubius Therapeutics price target lowered to $11 from $23 at Guggenheim
03/13/20 SVB Leerink
Rubius Therapeutics downgraded at SVB Leerink after RTX-134 discontinuation
03/13/20 Morgan Stanley
Rubius Therapeutics downgraded to Equal Weight from Overweight at Morgan Stanley
RUBY Rubius Therapeutics
$5.19 /

+0.04 (+0.78%)

RUBY Rubius Therapeutics
$5.19 /

+0.04 (+0.78%)

Earnings
Motorcar Parts reports Q1 EPS (16c), consensus (8c) » 08:10
08/10/20
08/10
08:10
08/10/20
08:10
MPAA

Motorcar Parts

$19.01 /

+0.74 (+4.05%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MPAA Motorcar Parts
$19.01 /

+0.74 (+4.05%)

07/01/20 B. Riley FBR
Motorcar Parts transferred with Buy rating at B. Riley FBR
06/19/20 Roth Capital
Motorcar Parts assumed with a Buy at Roth Capital
11/13/19 Roth Capital
Motorcar Parts price target raised to $25 from $17 at Roth Capital
09/04/19 Roth Capital
Motorcar Parts resumed with a Buy at Roth Capital
MPAA Motorcar Parts
$19.01 /

+0.74 (+4.05%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.